Harmony Biosciences (HRMY) director receives 21,872 stock options grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Harmony Biosciences Holdings, Inc. director Philip Ron M reported a compensation-related grant of stock options. He was awarded 21,872 stock options for Common Stock with an exercise price of $30.76 per share, all held directly after the grant.
The options expire on May 14, 2036 and will vest in full on the earlier of May 14, 2027 or the date of the next annual meeting following the grant, subject to his continued service. This filing reflects an acquisition of derivative securities, not an open-market share purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Philip Ron M
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 21,872 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 21,872 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 21,872 options
Exercise price: $30.76 per share
Expiration date: May 14, 2036
+2 more
5 metrics
Options granted
21,872 options
Stock option grant to director on May 14, 2026
Exercise price
$30.76 per share
Conversion or exercise price of granted options
Expiration date
May 14, 2036
Option expiration for director grant
Vesting date trigger
May 14, 2027
Latest full vesting date, or earlier next annual meeting
Post-transaction options held
21,872 options
Total derivative securities held directly after grant
Key Terms
Stock Option, grant/award acquisition, Common Stock, exercise price, +1 more
5 terms
Stock Option financial
"The stock option shall vest in full on the earlier to occur of"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
grant/award acquisition financial
"transaction_action": "grant/award acquisition""
Common Stock financial
"underlying_security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price": "30.7600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The stock option shall vest in full on the earlier to occur of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did Philip Ron M report in this Harmony Biosciences (HRMY) Form 4?
He reported a grant of 21,872 stock options for Harmony Biosciences Common Stock. These derivative securities were awarded as compensation rather than bought on the open market, and are held directly following the transaction according to the filing details.
What are the key terms of the 21,872 Harmony Biosciences stock options granted to Philip Ron M?
The grant covers 21,872 stock options with an exercise price of $30.76 per share. The options relate to Harmony Biosciences Common Stock and are scheduled to expire on May 14, 2036, giving a long-dated right to purchase shares at that price.
When do Philip Ron M’s Harmony Biosciences (HRMY) stock options vest?
The options vest in full on the earlier of May 14, 2027, or the date of the next annual meeting following the grant. Vesting is contingent on his continued service through the applicable vesting date, as described in the footnote.
How many Harmony Biosciences derivative securities does Philip Ron M hold after this grant?
After the reported transaction, he holds 21,872 stock options directly, matching the number granted in this filing. The derivativeSummary shows no additional option positions, so this grant represents the full derivative position visible in the reported data.